NOVN — Novartis Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣227.76bn
- CH₣246.59bn
- $56.33bn
- 99
- 29
- 96
- 91
Annual cashflow statement for Novartis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 24,018 | 6,955 | 8,572 | 11,939 | 13,967 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -11,714 | 4,404 | 2,403 | 5,517 | 6,144 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3,346 | -4,304 | -4,794 | -4,436 | -6,292 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 15,071 | 14,236 | 14,458 | 17,619 | 19,144 |
| Capital Expenditures | -2,971 | -2,671 | -2,753 | -3,814 | -3,900 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 7,179 | 4,139 | 8,349 | -3,699 | -977 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 4,208 | 1,468 | 5,596 | -7,513 | -4,877 |
| Financing Cash Flow Items | 94 | 55 | 3,478 | -207 | -294 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -16,264 | -20,562 | -14,278 | -11,742 | -14,867 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2,749 | -4,890 | 5,876 | -1,934 | -24 |